Episode notes
Blockchain for Precision Medicine
Robert Chu | Co-Founder & CEO, Embleema
Because evidence generation for precision medicine involves highly complex bioinformatics on human genomic and other molecular data sets, the reproducibility of the evidence generation and the sharing of highly sensitive raw genomic data present major challenges for life sciences sponsors and the FDA. Blockchain offers solutions for reproducibility and privacy assurance in precision medicine.